Andrew Bird

2.2k citations

31 papers · 1.7k · h-index 22

Impact in

Rheumatology top 2%
- Glycogen Storage Diseases and Myoclonus
Physiology top 5%
- Lysosomal Storage Disorders Research

Papers in

Genetics 9
- Neurogenetic and Muscular Disorders Research 9
- Virus-based gene therapy research 8
- Genetics and Neurodevelopmental Disorders 5
Physiology 14
- Lysosomal Storage Disorders Research 13

Co-authors: Dwight D. Koeberl (22 shared papers)Baodong Sun (15 shared papers)Gregory R. Mundy (2 shared papers)Chantal Chenu (1 shared paper)David Roodman (1 shared paper)Johannes Pfeilschifter (1 shared paper)Sarah P. Young (8 shared papers)Haoyue Zhang (5 shared papers)
Journals: Molecular Therapy (10 papers)Gene Therapy (4 papers)The Journal of Gene Medicine (2 papers)Clinical and Translational Allergy (2 papers)The FASEB Journal (2 papers)
Partner nations: United States Italy Taiwan

In The Last Decade

Andrew Bird

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Andrew Bird

Since Specialization

Citations

This map shows the geographic impact of Andrew Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bird more than expected).

Fields of papers citing papers by Andrew Bird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bird. The network helps show where Andrew Bird may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Bird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Bird Line = papers co-authored together Andrew Bird links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro Journal of Bone and Mineral Research ·Johannes Pfeilschifter, Chantal Chenu, Andrew Bird, Gregory R. Mundy, David Roodman	1989	414
2	Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II Molecular Therapy ·Luis Miguel Franco, Baodong Sun, Xiaoyi Yang, Andrew Bird, Haoyue Zhang, Ayn Schneider, Talmage T. Brown, Sarah P. Young	2005	147
3	Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. PubMed ·Roodman Gd, Andrew Bird, Denise H. Hutzler, Willi Montgomery	1987	135
4	Efficacy of an Adeno-associated Virus 8-Pseudotyped Vector in Glycogen Storage Disease Type II Molecular Therapy ·Baodong Sun, Haoyue Zhang, Luis Miguel Franco, Sarah P. Young, Ayn Schneider, Andrew Bird, Andrea Amalfitano, Y.-T. Chen	2004	122
5	Enhanced Response to Enzyme Replacement Therapy in Pompe Disease after the Induction of Immune Tolerance The American Journal of Human Genetics ·Baodong Sun, Andrew Bird, Sarah P. Young, Priya Sunil Kishnani, Yuqi Chen, Dwight D. Koeberl	2007	110
6	AAV Vector-mediated Reversal of Hypoglycemia in Canine and Murine Glycogen Storage Disease Type Ia Molecular Therapy ·Dwight D. Koeberl, Carlos R. F. Pinto, Baodong Sun, Songtao Li, Daniel M. Kozink, Daniel K. Benjamin, Amanda K. DeMaster, Meghan A. Kruse	2008	79
7	Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease Molecular Therapy ·Baodong Sun, Michael D. Kulis, Sarah P. Young, Amy C. Hobeika, Songtao Li, Andrew Bird, Haoyue Zhang, Yifan Li	2009	76
8	Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia Gene Therapy ·Dwight D. Koeberl, Baodong Sun, Tirupapuliyur V. Damodaran, Talmage T. Brown, David S. Millington, Daniel K. Benjamin, Andrew Bird, Ayn Schneider	2006	72
9	Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. Journal of Clinical Investigation ·Nobuhiro Takahashi, Toshio Kukita, Brian R. MacDonald, Andrew Bird, Gregory R. Mundy, Linda M. McManus, Myrna M. Miller, ALAN BOYDE	1989	71
10	Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria Gene Therapy ·Cary O. Harding, Melanie B. Gillingham, Kelly Jo Hamman, Heather D. Clark, E Goebel-Daghighi, Andrew Bird, D.D. Koeberl	2005	71
11	Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors Gene Therapy ·R M Beaty, Mark W. Jackson, David A. M. Peterson, Andrew Bird, Talmage T. Brown, Daniel K. Benjamin, Tarja A. Juopperi, Priya Sunil Kishnani	2002	50
12	Enhanced Efficacy of an AAV Vector Encoding Chimeric, Highly Secreted Acid α-Glucosidase in Glycogen Storage Disease Type II Molecular Therapy ·Baodong Sun, Haoyue Zhang, Daniel K. Benjamin, Talmage T. Brown, Andrew Bird, Sarah P. Young, Alison J. McVie-Wylie, Y.-T. Chen	2006	47
13	Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease The FASEB Journal ·Songtao Li, Baodong Sun, Mats Inge Nilsson, Andrew Bird, Mark Andrew Tarnopolsky, Beth L. Thurberg, Deeksha Sarihyan Bali, Dwight D. Koeberl	2012	39
14	Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia Human Gene Therapy ·Amanda K. DeMaster, Xiaoyan Luo, Sarah W. Curtis, Kyha D. Williams, Dustin J. Landau, Elizabeth J. Drake, Daniel M. Kozink, Andrew Bird	2011	32
15	Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector Molecular Therapy ·Xiaoyan Luo, Gentzon Hall, Songtao Li, Andrew Bird, Peter Lavin, Michelle P. Winn, Alex R. Kemper, Talmage T. Brown	2011	31
16	Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector Molecular Therapy ·Baodong Sun, Y.-T Chen, Andrew Bird, Andrea Amalfitano, Dwight D. Koeberl	2003	30
17	Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia Molecular Therapy ·Dwight D. Koeberl, Baodong Sun, Andrew Bird, Ying‐Ting Chen, Koichiro Oka, Lawrence Chan	2007	29
18	Packaging of an AAV vector encoding human acid α-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector Molecular Therapy ·Baodong Sun, Y.-T Chen, Andrew Bird, Fang Xu, Yang-Xun Hou, Andrea Amalfitano, Dwight D. Koeberl	2003	26
19	Antibody formation and mannose‐6‐phosphate receptor expression impact the efficacy of muscle‐specific transgene expression in murine Pompe disease The Journal of Gene Medicine ·Baodong Sun, Songtao Li, Andrew Bird, Haiqing Yi, Alex R. Kemper, Beth L. Thurberg, Dwight D. Koeberl	2010	26
20	In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA Molecular Therapy ·Dustin J. Landau, Elizabeth Drake Brooks, Pablo Pérez‐Piñera, Hiruni S. Amarasekara, Adam L. Mefferd, Songtao Li, Andrew Bird, Charles A. Gersbach	2016	25

About Andrew Bird

Andrew Bird is a scholar working on Genetics, Physiology, Genetics, Rheumatology and Physiology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (13 papers), Neurogenetic and Muscular Disorders Research (9 papers), Virus-based gene therapy research (8 papers), Glycogen Storage Diseases and Myoclonus (7 papers), Genetics and Neurodevelopmental Disorders (5 papers), Trypanosoma species research and implications (5 papers), CRISPR and Genetic Engineering (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Rheumatology (418 citations), Physiology (600 citations), Genetics (555 citations), Physiology (90 citations) and Genetics (178 citations). Andrew Bird has collaborated with scholars based in United States, Italy and Taiwan. Frequent co-authors include Dwight D. Koeberl, Baodong Sun, Gregory R. Mundy, Chantal Chenu, David Roodman, Johannes Pfeilschifter, Sarah P. Young, Haoyue Zhang, Talmage T. Brown and Songtao Li. Their work appears in journals such as Molecular Therapy, Gene Therapy, The Journal of Gene Medicine, Clinical and Translational Allergy and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Andrew Bird

Impact in

Papers in i

In The Last Decade

Andrew Bird

Peers

Countries citing papers authored by Andrew Bird

Fields of papers citing papers by Andrew Bird

All Works

About Andrew Bird

Explore authors with similar magnitude of impact

Papers in